High-Intensity Functional Training Combined with Hibiscus sabdariffa Supplementation and Cardiovascular Risk Factors

High-Intensity Functional Training Combined with Hibiscus sabdariffa Supplementation Improves Cardiovascular Risk Factors in Overweight and Obese Men: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241205063953N1

Enrollment

Registered

2025-01-08

Start date

2024-08-20

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular risk factors (Obesity, Hypertension, Dyslipidemia). Overweight and obesity

Interventions

Intervention 1: Intervention group: In this group, participants undergo a high-intensity functional training (HIFT) program for 12 weeks. The program consists of three sessions per week, each lasting

Eligibility

Sex/Gender

Male

Age

20 Years to 25 Years

Inclusion criteria

Inclusion criteria: Men aged 20-25 years with a body mass index (BMI) between 25 and 35 kg/m² No history of regular physical activity in the past 12 months No medical conditions contraindicating intense physical activity (e.g., heart diseases) Willingness to participate in the study and sign an informed consent form

Exclusion criteria

Exclusion criteria: Individuals allergic to Hibiscus sabdariffa Use of antioxidant drugs or supplements within the past three months

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: using a mercury sphygmomanometer.;Lipid Profile: total cholesterol, LDL, HDL, and triglycerides. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Blood tests using enzymatic methods for total cholesterol, LDL, HDL, and triglycerides.;CRP. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Measured using the ELISA method.;Anthropometric Variables: weight, body mass index (BMI), and body fat percentage. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Weight: Measured using a digital scale - BMI: Calculated using the formula weight (kg) divided by height (m) squared - Body Fat Percentage: Measured using a Bioelectrical Impedance Analysis (BIA) device.	—

Measure

Time frame

Blood pressure. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: using a mercury sphygmomanometer.;Lipid Profile: total cholesterol, LDL, HDL, and triglycerides. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Blood tests using enzymatic methods for total cholesterol, LDL, HDL, and triglycerides.;CRP. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Measured using the ELISA method.;Anthropometric Variables: weight, body mass index (BMI), and body fat percentage. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Weight: Measured using a digital scale - BMI: Calculated using the formula weight (kg) divided by height (m) squared - Body Fat Percentage: Measured using a Bioelectrical Impedance Analysis (BIA) device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAkram Jafari

Islamic Azad University

jafari.akm@gmail.com+98 383361001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026